Cell Therapies for Parkinson's Disease [F-15-11]
| Presenter: | Shantanu Sur |
|---|---|
| Location: | SUNY Potsdam: Maxcy 104 |
| Classes: | 1 Session 1.5 hours |
| Dates: | Fri 10:00 AM 10/30 |
| Status: | CLOSED |
Print Info
This presentation will focus on the promise and challenges of new biomaterials that are used to treat Parkinson’s Disease (PD). One such mainstay treatment is a continuous replenishment of dopamine through external administration, but its effectiveness is frequently limited by the development of drug resistance and side effects. Another treatment is the reestablishment of lost dopaminergic (DA) neuronal innervation in PD by implanting DA neurons in the striatum region of the brain. This treatment has shown promise for long-term recovery. However, one shortcoming of this approach is the poor survival rate of the transplanted cells.
Shantanu Sur is currently an assistant professor in the Department of Biology at Clarkson University. His research focuses on the design of functional biomaterials, studying cell-material interactions at nanoscale, and using material scaffolds to develop cell-based therapies. He is hoping the results from these studies will translate into new strategies for neural regeneration.